BEERSE, Belgium, April 27 /PRNewswire/ -- Janssen-Cilag International NV announced today that the Committee for Human Medicinal Products (CHMP) in the European Union, has granted a positive opinion recommending approval of INVEGA(R) (paliperidone prolonged release tablets).
From: www.redorbit.com
R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia
Posted by Ruslan Abuzant at 11:32 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment